Article
IHGAMP: Pan-cancer HRD prediction from routine H&E whole-slide images using foundation models
2025-12-20
Abstract excerpt
Homologous recombination deficiency (HRD) confers sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors and platinum-based chemotherapy, representing a critical biomarker for precision oncology across multiple malignancies. Current HRD assessment relies on next-generation sequencing of genomic scar signatures, but specialized infrastructure requirements, high costs, and prolonged turnaround times limit wid...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c36f020d-35c7-5ab5-8a1c-51fbb369eb80
- DOI
- 10.64898/2025.12.19.25342650
